The strategic recruitment extends the company’s management team and enhances their ability to execute on the mission: to deliver high quality products for scientific and clinical applications.
Hanna brings extensive experience from the In Vitro Diagnostics industry, most recently from a senior position at Thermo Fisher Scientific. Her substantial knowledge in quality and regulatory compliance combined with her engineering background, skills within product development as well as first-hand experience from implementation of quality management systems and regulatory file submissions, really make her the perfect fit for the role.
“Hanna not only adds the competence and expertise we need, but also the right attitude and grit needed for an early-stage product and company. I’m confident that Hanna will make a great addition to the team and thrive in her role.”
– Linus Bosaeus, CEO.
Hanna joined the team March 28th 2022, and will be based at the main office in Uppsala.
“I am very excited to join Rarity Bioscience and be part of the journey ahead. For a startup company to add quality and regulatory resources in the initial phase, is for me evidence of insights from executive management on regulatory landscape for diagnostic products and a deliberate leadership. To early on implement a quality management system will be the foundation for building a great organization.”
– Hanna Kocken.
